Related Experiment Video
Updated: Jun 19, 2026
09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations
1Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
AJNR. American Journal of Neuroradiology
|October 17, 2009
Summary
Diffusion Tensor Imaging (DTI) reveals white matter abnormalities in Rett syndrome (RTT). Fractional Anisotropy (FA) changes in RTT correlate with speech ability, offering a new measure of clinical severity.
Area of Science:
- Neuroscience
- Medical Imaging
- Genetics
Background:
- Rett syndrome (RTT) is a neurodevelopmental disorder caused by mutations in the methyl CpG binding protein 2 (MeCP2) gene.
- RTT affects neuronal maturation and connectivity, leading to significant clinical challenges.
Purpose of the Study:
- To prospectively investigate white matter tract abnormalities in RTT patients using Diffusion Tensor Imaging (DTI).
- To correlate Fractional Anisotropy (FA) values with specific clinical features in RTT.
Main Methods:
- DTI was performed on 32 RTT patients and 37 age-matched healthy female controls using a 1.5T MR imaging unit.
- Neurologic assessments were conducted, and FA was evaluated across multiple brain regions to identify tract-specific abnormalities.
Main Results:
- Patients with RTT showed significant reductions in FA in several white matter tracts, including the corpus callosum and internal capsule.
- FA in visual pathways was comparable to controls. FA in the superior longitudinal fasciculus correlated with speech ability, being preserved in verbal patients and reduced in nonverbal ones.
- No significant correlations were found between FA values and clinical features like seizures, motor skills, or head circumference.
Conclusions:
- DTI is a noninvasive technique that can assess white matter pathology in RTT.
- FA measurements may enhance the clinical severity assessment of RTT, complementing existing classifications based on MeCP2 gene mutations and X-inactivation.
